Biomarker discovery analysis revealed that three immune checkpoint molecules, specifically CD40, CD27, and TIM-3, exhibit excellent or good discriminatory properties for cervical carcinoma compared to healthy controls and dysplasia. This evidence concerns the gene HAVCR2 and dysplasia.